Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
ConocoPhillips
COP
|
+$3.33B |
| 2 |
Merck
MRK
|
+$2.61B |
| 3 |
Schlumberger
SLB
|
+$1.65B |
| 4 |
Target
TGT
|
+$1.34B |
| 5 |
General Mills
GIS
|
+$926M |
Top Sells
| 1 |
Pfizer
PFE
|
+$2.72B |
| 2 |
Blackrock
BLK
|
+$2.48B |
| 3 |
US Bancorp
USB
|
+$1.68B |
| 4 |
M&T Bank
MTB
|
+$762M |
| 5 |
Huntington Bancshares
HBAN
|
+$554M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Novartis
NVS
$240B
| $20.7M | ﹤0.01% |
185,603
+20,161
| +12% | +$2.25M |
|
1627
Peabody Energy
BTU
$2.24B
| $20.6M | ﹤0.01% |
1,518,351
+118,307
| +8% | +$1.6M |
|
1628
Tidewater
TDW
$2.93B
| $20.6M | ﹤0.01% |
486,644
-4,149
| -0.8% | -$175K |
|
1629
Amdocs
DOX
$9.35B
| $20.5M | ﹤0.01% |
224,076
+10,766
| +5% | +$985K |
|
1630
Transmedics
TMDX
$3.91B
| $20.5M | ﹤0.01% |
304,367
+6,934
| +2% | +$467K |
|
1631
Teladoc Health
TDOC
$1.36B
| $20.5M | ﹤0.01% |
2,571,673
+127,960
| +5% | +$1.02M |
|
|
QXO
1632
QXO Inc
QXO
$14B
| $20.4M | ﹤0.01% |
1,506,186
-38,038
| -2% | -$515K |
|
1633
Teva Pharmaceuticals
TEVA
$22.9B
| $20.4M | ﹤0.01% |
1,324,936
+296,012
| +29% | +$4.55M |
|
1634
First Bancorp
FBNC
$2.29B
| $20.3M | ﹤0.01% |
506,609
-688
| -0.1% | -$27.6K |
|
|
TWO
1635
Two Harbors Investment
TWO
$1.05B
| $20.3M | ﹤0.01% |
1,521,548
-20,910
| -1% | -$279K |
|
1636
Amicus Therapeutics
FOLD
$2.46B
| $20.3M | ﹤0.01% |
2,491,080
-95,723
| -4% | -$781K |
|
1637
First Busey Corp
BUSE
$2.19B
| $20.3M | ﹤0.01% |
937,591
+230,268
| +33% | +$4.97M |
|
1638
Coca-Cola Europacific Partners
CCEP
$40.7B
| $20.1M | ﹤0.01% |
231,420
-10,457
| -4% | -$910K |
|
1639
Twist Bioscience
TWST
$1.53B
| $20.1M | ﹤0.01% |
512,415
-30,417
| -6% | -$1.19M |
|
1640
Vericel Corp
VCEL
$1.62B
| $20.1M | ﹤0.01% |
449,615
-1,849
| -0.4% | -$82.5K |
|
1641
Pegasystems
PEGA
$9.93B
| $20M | ﹤0.01% |
576,316
-46,280
| -7% | -$1.61M |
|
1642
Ennis
EBF
$463M
| $20M | ﹤0.01% |
995,093
+725,379
| +269% | +$14.6M |
|
1643
Acadia Pharmaceuticals
ACAD
$3.98B
| $19.9M | ﹤0.01% |
1,200,839
-50,493
| -4% | -$839K |
|
1644
Tronox
TROX
$767M
| $19.9M | ﹤0.01% |
2,832,510
+375,643
| +15% | +$2.64M |
|
1645
Federal Agricultural Mortgage
AGM
$2.15B
| $19.9M | ﹤0.01% |
106,253
+4,963
| +5% | +$931K |
|
1646
CAE Inc
CAE
$8.47B
| $19.9M | ﹤0.01% |
807,985
-20,866
| -3% | -$513K |
|
1647
Braze
BRZE
$3.35B
| $19.9M | ﹤0.01% |
550,355
+12,409
| +2% | +$448K |
|
1648
Scholar Rock
SRRK
$3.04B
| $19.8M | ﹤0.01% |
617,107
-5,302
| -0.9% | -$170K |
|
1649
C3.ai
AI
$2.26B
| $19.5M | ﹤0.01% |
928,592
-4,547
| -0.5% | -$95.7K |
|
1650
Chemours
CC
$2.51B
| $19.5M | ﹤0.01% |
1,438,732
+136,460
| +10% | +$1.85M |
|